William Solomon
Hematology & Oncology · Brooklyn, NYNPI 1245225275
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $31,315 of the $34,129 with a category attached, or 91.8%. E.r. Squibb & Sons, L.L.C. accounts for 85.9% of it on its own, with 24 other manufacturers making up the rest.
Across 112 payments — averaging $304.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$29K
- Novartis$4K
- Bayer$192
- Exelixis Inc.$136
- Takeda Pharmaceuticals U.S.A., Inc.$111
- Astellas Pharma US Inc$105
- plus $715 from 19 others
Across 1 payment — averaging $350.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$350
What the payments were for
- Speaking & faculty fees$31,31592%
- Food & beverage$2,7548%
- Education$600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 39 | $29,300 |
| Novartis | 12 | $3,568 |
| Bayer | 8 | $192 |
| Exelixis Inc. | 6 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $111 |
| Astellas Pharma US Inc | 4 | $105 |
| Merck | 4 | $70 |
| AstraZeneca | 4 | $70 |
| Rigel Pharmaceuticals, Inc. | 3 | $66 |
| Pfizer | 5 | $66 |
| Lilly USA, LLC | 3 | $61 |
| Gilead | 3 | $50 |
| Boehringer Ingelheim | 2 | $46 |
| EMD Serono, Inc. | 1 | $42 |
| Tersera Therapeutics LLC | 3 | $41 |
| Taiho Oncology, Inc. | 2 | $38 |
| GSK | 1 | $29 |
| Tesaro, Inc. | 1 | $28 |
| Johnson & Johnson | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Incyte Corporation | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| Sanofi | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$34,129 in reported general payments places this provider in the 85th percentile of 967 hematology & oncology providers in New York.
Other hematology & oncology in Brooklyn
- Perry CookBrooklyn$803K
- Ilya BlokhBrooklyn$220K
- Yiwu HuangBrooklyn$220K
- Songchuan GuoBrooklyn$129K
- Michael SchusterNew York$1.6M
- Charles SawyersNew York$1.6M
- Manuel Hidalgo-MedinaNew York$1.4M
- Francis ArenaLake Success$1M
- Sanjeev JainEast Patchogue$971K
- Ross LevineNew York$968K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.